Skip to content
Home » Valentine's Day » Pfizer vaccine gains emergency authorization for 12-15 year olds

Pfizer vaccine gains emergency authorization for 12-15 year olds

The U.S. Food and Drug Administration has extended emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine to 12 to 15-year-olds.

The FDA said it had determined that Pfizer-BioNTech COVID-19 Vaccine met the statutory criteria to amend the Emergency Use Authorization, and that the known and potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks, supporting the vaccine’s use.


Pfizer announced in March that data from a phase 3 trial showed the vaccine was 100% effective in preventing COVID-19 in adolescents.

The Moderna and Johnson & Johnson COVID-19 vaccines are only authorized for people 18 and older.

Experts say vaccinating children will be crucial to reaching herd immunity in communities across the state and country.



Top